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ABSTRACT
Noninvasive mechanical ventilation (NIMV) has been widely 
applied to the patient with respiratory failure since 1990’s around 
the world. The respiratory function of the patient with respiratory 
failure should be supported by using positive pressure ventilation 
until primary problem of the patient is treated. Positive pressure 
should be given noninvasively or invasively. If the patient is 
conscious (except unconsiousness due to CO2 retention) and has 
intact bulber function(sufficient cough reflex and swallowing 
function)  and has stable clinical picture, we have to use NIMV 
instead of invasive mechanical ventilation (IMV). NIMV can be 
applied to the patient outside of the intensive care unit. The side 
effects of mechanical ventilation are significantly decreased during 
NIMV than that of IMV.
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Indications
Increased respiratory work that can be progressed to 
respiratory failure (respiratory rate>35/min, intercostal 
retractions, supraclavicular retractions, paradoxical 
breathing), respiratory failure and respiratory arrest are 
indications of mechanical ventilation in all diseases. 
Mechanical ventilatory support can be provided 
noninvasively if the patient is conscious (except 
unconsciousness due to CO2 retention) and has intact 
bulbar function (sufficient cough reflex and swallowing 
function) and has stable clinical picture. Mechanical 
ventilatory support is delivered to the patient through 
interfaces (nasal, oro-nasal, full face, helmet) during 
noninvasive mechanical ventilation (NIMV), but by using 
endotracheal tube or tracheotomy cannula during invasive 
mechanical ventilation (IMV). If NIMV is contraindicated, 
respiratory support should be given by using IMV. It is 
possible to avoid complications of intubation and IMV by 
using NIMV.
Definition: NIMV is delivery of positive pressure 
ventilation to support respiratory function of the patient 
through interfaces. 
Indications of mechanical ventilation
Figure 1.  Algorithm for indications of mechanical ventilation. 
NIMV: Non invasive mechanical ventilation, IMV: Invasive 
mechanical ventilation
The respiratory function of the patient with respiratory 
failure should be supported by using mechanical ventilation, 
until primary problem of the patient is treated. There is no 
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difference in terms of degree of support between NIMV 
and IMV. The same respiratory support is delivered through 
mask during NIMV or by using endotracheal tube during 
IMV. The patient should be evaluated in conjunction with 
arterial blood gas and respiratory effort. The patient may 
have extreme unacceptable respiratory effort to reach normal 
blood gas value. This patient has tendency to respiratory 
failure. Mechanical ventilatory support must be given to 
patient without waiting for the results of arterial blood gas. 
Acute respiratory distress syndrome (ARDS) and shock are 
referred to as the clinical situations that are unstable; in such 
cases, if the patient’s ventilatory support is lost for a short 
period of time, hypoxemia will create serious irreversible 
problems. In the clinical pictures like this, IMV is a more 
secure modality.
Place of NIMV
Figure 2. Choose the place to administer NIMV
Contraindications of NIMV
Table I.  Contraindications of NIMV
NIMV practice
Figure 3.  NIMV practice 
The success of NIMV is highly dependent on patient 
cooperation. The physician should serve the role of 
facilitator, motivating the patient, explaining the purpose of 
equipment, and preparing the patient for process. Patients 
should be reassured and frequently encouraged. 
The support of mechanical ventilator is given by a 
controlled mode (volume or pressure control) to the patients 
who are unconscious or have respiratory center depression, 
because the failure rate of NIMV is high in these groups 
of patients.  Effective ventilation, by reducing the level of 
PaCO2, allows the patient to recover consciousness and 
then pressure support ventilation (PSV) or one of the other 
assisted modes can be applied. Mechanical ventilatory 
support of 25-30 cm H2O of pressure or 500 mL of volume 
during controlled ventilation as initial adjustment can 
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be given. If the patient compliance to ventilator is not so 
good, less tidal volume can be achieved by given pressure 
so it is important to remember that the patient may remain 
hypoventilated. If the patient keeps awake, success of 
NIMV increases significantly in the assisted modes like 
PSV. Another option in these patients is the application of 
Average Volume Guaranteed Pressure Support (AVAPS) 
mode.
Assessment of success
NIMV will be successful if the amount of expired tidal 
volume is more than 5 ml/kg or 300 mL. If the expired tidal 
volume is less than 300 mL, recovery of the patient does not 
occur. So, it is not feasible for us to wait first hour to assess 
NIMV. The 20% change in respiratory rate, PaCO2, PaO2 or 
pH at first and/or forth hour, a good or bad way is considered 
meaningful. The changes of respiratory effort are monitored. 
Generally, clinical improvement is firstly observed, and then 
improvement of gas exchange develops. If the patient lung 
reserve is not good, clinical picture of the patient may begin 
to recover, but improvement of pH and PaCO2 may delay.
Figure 4. Assessment of success.
Table II. Clinical pictures and level of evidences that are 
successfully treated by NIMV (change from 2)
Complications and treatments
Figure  5. Complications of NIMV and treatments 
Follow up: If the patient has criteria indicating NIMV failure, 
the patient should be admitted to ICU. Close monitoring is 
necessary for these patients.
NIMV vs. High-flow oxygen therapy (HFOT) 
HFOT through a nasal cannula is a technique whereby 
heated and humidified oxygen is delivered to the nose at 
high flow rates. These high flow rates generate low levels of 
positive pressure (approximately 1 cm H2O for every 10L/
min flow) in the upper airways [1-5]. The high flow rates 
may also decrease physiological dead space by flushing 
expired carbon dioxide from the upper airway, decrease in 
the work of breathing is observed.
HFOT serve as an important alternative to NIMV 
especially in the management the patients with hypoxemic 
respiratory failure. The rate of treatment failure with NIMV 
is as high as 50% in patients who have contraindication 
of NIMV such as facial surgery, impaired swallowing and 
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cough. In HFOT a special nasal cannula is used, thus HFOT 
does not interfere with eating and speaking. 
HFOT is not suitable in patients with hypercapnic 
respiratory failure.
If the patient receives FiO2 of greater than 60% and 
more than 48 hours, the patient may be at the risk of oxygen 
toxicity. Positive pressure ventilation improves oxygenation 
and CO2 removal by alveolar recruitment, increasing 
alveolar volume and redistribution of extracellular lung 
water. So it is reasonable to implement positive pressure 
ventilation in patients on high O2 like this level [6].
Mechanical ventilation vs. Extracorporeal membrane 
oxygenation (ECMO)/ Extra corporeal CO2 removal 
(ECCOR)  
Venoarterial ECMO is preferred if cardiac function is 
depressed and cardiac support is also required. Patients with 
severe respiratory failure and secondary cardiac failure may 
improve on venovenous ECMO support alone. ECCOR 
is provided to remove CO2 and, unlike ECMO, does not 
provide significant oxygenation. In contrast to ECMO, 
where the need for oxygenation requires high blood flow 
rates, ECCOR allows much lower blood flow rates (500-
1000mL/min) and needs smaller access cannulas. So, 
ECCOR promises to improve safety and ease of use. If 
the patient has sufficient arterial pressure (arteriovenous 
pressure gradient ≥ 60 mm Hg), a pumpless system can be 
used in ECCOR. Otherwise, a mechanical pump should be 
used [7].
ECCOR provide prevention of ventilator induced lung 
injury associated with ultra-protective ventilation (3-4mL/
kg VT) during severe ARDS treatment, end-stage COPD 
respiratory failure and as a bridge to lung transplant [8].
NIMV compared to IMV has been demonstrated to 
reduce mortality by approximately 50% respiratory failure 
in COPD patients [9]. However, approximately 25% of these 
patients will fail NIMV and require IMV [10]. It has been 
reported that COPD patients who require IMV have high 
mortality rate and were also at increased risk of weaning 
failure and prolonged ventilation. ECCOR has been utilized 
to avoid intubation, to facilitate weaning and to reduce 
length of IMV in COPD patients.  It is possible that in 
patients suffering from COPD exacerbations with NIVM 
failure, it could be possible to avoid intubation with the 
implementation of ECCOR in order to correct respiratory 
acidosis and hypercapnia until recovery of gas exchange and 
an improvement in the dynamic hyperinflation [8].
References
1.  Mehta S, Hill N. Non invasive ventilation. Am J Respir Crit 
Care Med 2001;163:540-77.
2.  Ferrer M, Esquinas A, Leon M,  et al. Noninvasive ventilation 
in severe hypoxemic respiratory failure: a randomized clinical 
trial. Am J Respir Crit Care Med 2003;168:1438-44.
3.  Polderman KH. Mechanisms of action, physiological effects, 
and complications of hypothermia. Crit Care Med 2009;37(7 
Suppl): S186-202.
4.  Mild therapeutic hypothermia to improve the neurologic 
outcome after cardiac arrest. N Engl J Med 2002;346: 549-56.
5.  Bernard  SA, Gray TW, Buist MD, et al. Treatment of 
comatose survivors of out-of-hospital cardiac arrest with 
induced hypothermia. N Engl J Med 2002;346: 557-63.
6.  Cove, ME, MacLaren G, Federspiel  WJ, Kellum JA. Bench 
to bedside review: Extracorporeal carbon dioxide removal, 
past present and future. Crit Care 2012;16:232.
7.  Ward JJ. High-flow oxygen administration by nasal cannula 
for adult and perinatal patients. Respir Care 2013;58: 98-122.
8.  Cardenas VJ Jr, Lynch JE, Ates R, et al. Venovenous carbon 
dioxide removal in chronic obstructive pulmonary disease: 
experience in one patient. ASAIO J 2009; 55: 420–2.
9.  Brochard L, Mancebo J, Wysocki M, et al.  Noninvasive 
ventilation for acute exacerbations of chronic obstructive 
pulmonary disease. N Engl JMed 1995; 333:817–22.
10.  Quinnell TG, Pilsworth S, ShneersonJM, Smith IE. Prolonged 
invasive ventilation following acute ventilatory failure in 
COPD: weaning results, survival, and the role of noninvasive 
ventilation. Chest 2006; 129:133–9.
